Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
From 31 May 1979 To 11 Jul 1979
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1982
Report date:
1982

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
yes
Remarks:
occlusive patch held for 24 hours instead of 6 hours; 10 instead of 20 animals
Principles of method if other than guideline:
Modified Buehler-test with 10 inductions
GLP compliance:
not specified
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
Currently no LLNA study is available for assessment. The Guinea Pig Maximization Test (GPMT) has been carried out as an animal test to predict human sensitization for over a decade and is recommended by international test guidelines such as OECD.

Test material

Constituent 1
Chemical structure
Reference substance name:
Bis(2-propylheptyl) phthalate
EC Number:
258-469-4
EC Name:
Bis(2-propylheptyl) phthalate
Cas Number:
53306-54-0
Molecular formula:
C28H46O4
IUPAC Name:
1,2-bis(2-propylheptyl) benzene-1,2-dicarboxylate
Test material form:
liquid

In vivo test system

Test animals

Species:
guinea pig
Strain:
other: albino
Sex:
male/female
Details on test animals and environmental conditions:
TEST ANIMALS
- Weight at study initiation: between 300 and 400 g
- Housing: housed and maintained in compliance with the Animal Welfare Act (Pub. L-94-279) 9 CFR part 3

Study design: in vivo (non-LLNA)

Induction
Route:
epicutaneous, occlusive
Vehicle:
unchanged (no vehicle)
Concentration / amount:
100%; 0.5 g
Challenge
Route:
epicutaneous, occlusive
Vehicle:
unchanged (no vehicle)
Concentration / amount:
100%; 0.5 g
No. of animals per dose:
5 male and 5 female
Details on study design:
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 10
- Exposure period: 20 d
- Test groups: 10 animals
- Control group: no
- Site: the same intact skin test site
- Patch: gauze patch was placed over the treated area and an impervious material was wrapped tightly around the trunks of the animals to hold the patch in place.
- Frequency of applications: every second day
- Duration: 24 h
- Concentrations: 100%

B. CHALLENGE EXPOSURE
- No. of exposures: 2
- Day(s) of challenge: after a 14 day rest period
- Exposure period: 24 h
- Test groups: 10 animals
- Control group: no
- Site: other skin site than used for induction
- Concentrations: 100%
- Evaluation (hr after challenge): 24, 48 h

SCORING
Sites were examined for irritation (if any) using the Draize Method of Scoring.
Challenge controls:
no
Positive control substance(s):
not specified

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
100%
No. with + reactions:
0
Total no. in group:
10
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
100%
No. with + reactions:
0
Total no. in group:
10
Group:
positive control
Remarks on result:
not measured/tested
Group:
negative control
Remarks on result:
not measured/tested

Any other information on results incl. tables

Individual scoring:

Animal Sex Irritation Readings after application No. Challenge
1 2 3 4 5 6 7 8 9 10 24 h 48 h
1 M Erythema 0 0 0 0 0 0 0 0 0 0 0 0
Edema 0 0 0 0 0 0 0 0 0 0 0 0
2 M Erythema 0 0 0 0 1 1 1 1 1 1 0 0
Edema 0 0 0 0 0 0 0 0 0 0 0 0
3 M Erythema 0 0 0 0 1 1 1 1 1 1 0 0
Edema 0 0 0 0 0 0 0 0 0 0 0 0
4 M Erythema 0 0 0 0 0 0 0 0 0 0 0 0
Edema 0 0 0 0 0 0 0 0 0 0 0 0
5 M Erythema 0 0 0 0 1 1 1 1 1 1 0 0
Edema 0 0 0 0 0 0 0 0 0 0 0 0
6 F Erythema 0 0 0 0 0 0 0 0 0 0 0 0
Edema 0 0 0 0 0 0 0 0 0 0 0 0
7 F Erythema 0 0 0 0 0 0 0 0 0 0 0 0
Edema 0 0 0 0 0 0 0 0 0 0 0 0
8 F Erythema 0 0 0 0 0 1 1 0 1 1 0 0
Edema 0 0 0 0 0 0 0 0 0 0 0 0
9 F Erythema 0 0 0 0 0 0 0 0 0 0 0 0
Edema 0 0 0 0 0 0 0 0 0 0 0 0
10 F Erythema 0 0 0 0 0 0 0 0 0 0 0 0
Edema 0 0 0 0 0 0 0 0 0 0 0 0

The test substance was not a primary irritant. It is not a skin sensitizer.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met